www.rehabpub.com/press_release.asp?id=10169642 -
[Cached Version]
Published on: 10/16/2007
Last Visited: 10/16/2007
"Esophageal cancer is as lethal as lung cancer and is one of the fastest growing cancers in the Western world right now," says Tim Askew
, president and CEO of CSA Medical."More than 6 million people in the U.S. have Barrett's esophagus, while 65 million people suffer from GastroEsophageal Reflux Disease (GERD), also called "acid reflux" or "heartburn".Approximately 350,000 persons with GERD develop more dangerous lesions, while 15,000 develop cancer annually, according to Askew.
CSA Medical's CryoSpray Ablation (TM) platform sprays liquid nitrogen on pre-cancerous or cancerous tissue, freezing and killing the malignant cells.Malignant cells die and slough off harmlessly, while normal tissue grows back.
"Most patients don't feel any significant pain and say it is a non-event," says Askew."One patient said that finding parking was more difficult than the procedure.No other therapy for this type of cancer allows tissue to grow back naturally without the potential for scarring," Askew added.
...
"The MIPS funding allowed us to validate our early clinical trial data in a major university hospital with a prominent physician," said Askew.